Home 2019
Archives
AHA: Impella Use Up for PCI Patients Needing Heart Pump
However, Impella use linked to increased odds of death, bleeding, stroke
AHA: Lower-Target LDL Level Beneficial After Stroke, TIA
Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis
AHA: Neurohormonal Blockade Beneficial for Patients With LVAD
At four years, survival better among patients with LVADs receiving any NHB medication at six months
AHA: Predictors for Meeting LDL-C, SBP Goals ID’d in ISCHEMIA
Older age, male sex, high-intensity statin use, lower baseline LDL-C predict LDL-C goal attainment
About Half of Middle-Age Adults Believe They May Develop Dementia
Only 5.2 percent of patients had discussed dementia prevention with their physician
AHA: Impact of Valsartan Recall Examined for Ontario, Canada
Immediate increase in emergency department visits for hypertension seen after generic valsartan recall
AHA: Risk for Ischemic CV Events Lower With Colchicine After MI
Risk for composite efficacy end point reduced with colchicine versus placebo after myocardial infarction
AHA: Many With Atherosclerotic CVD Not Meeting LDL-C Goals
Of those patients receiving only a statin, 67.0 percent did not achieve recommended LDL-C goal
AHA: Risk for Death Cuts Benefit of Oral Anticoagulants for A-Fib
Findings seen among older patients with incident atrial fibrillation receiving warfarin or apixaban
AHA: Vitamin D, Omega-3 Do Not Cut Heart Failure Hospitalization
However, marine n-3 supplementation appears to reduce recurrent heart failure hospitalization
